Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

Klaus Kopka(German Cancer Research Center), John W. Babich(RaNA Therapeutics (United States))
Journal of Nuclear Medicine
September 1, 2017
Cited by 156


Related Papers